While this price still places it above some branded and generic injectors, the convenience and ease of administration make it an attractive option for many. Furthermore, ARS Pharmaceuticals has introduced several programs aimed at making Neffy more accessible such as the neffyConnect program, in partnership with BlinkRx. Eligible commercially insured patients can purchase two single-use Neffy devices for just $25 via a co-pay savings program. For uninsured patients or those without coverage for Neffy, the cash price is set at $199 for two devices, with further support available through the ARS Patient Assistance Program for those who qualify. This pricing structure not only makes Neffy more competitive but also reflects ARS Pharmaceuticals's commitment to accessibility.